JUN INNOVATIONS INC
Biotech · Private
Magnetic supercooling device for biological material preservation using oscillating magnetic fields to prevent ice nucleation
- Grants
- $1.2M
- 5 awards
- Sector median: 1
- Raised
- —
- No Form D on record
- Contracts
- —
- No federal contracts on record
- Patents
- —
- No published records under this name
- Sector median: 2
Capital Timeline
Federal ↑Equity ↓201620182020202220242026
| Date | Event | Source | Amount |
|---|---|---|---|
| Federal grant | Department of Agriculture · Design Of A Supercooling Device For Extended Shelf Life Of Perishable Foods | $99,468 | |
| Federal grant | Department of Agriculture · Commercialized Supercooling Technology For Subzero Nonfreezing Preservation Of Fresh Foods | $596,592 | |
| Federal grant | Department of Agriculture · Enhanced Bacterial Viability Of Freeze-dried Probiotics Using The Supercooling Pretreatment | $100,000 | |
| Federal grant | Department of Health and Human Services · Phase I · Oscillating Magnetic Field Assisted Supercooling Preservation of Fresh and Unfrozen Ovaries at Subzero Temperatures | $275,001 | |
| Federal grant | Department of Agriculture · Supercooling Is A Decent Technology That Preserves Food Materials At Below-freezing Temperatures Without Formation Of Ice Crystals. Foods Are Maintained In Their Natural State For Weeks With The Same Taste, Texture, Nutrition, And Moisture Content They Had Before Being Supercooled. This Technology Can Offer A Radically New Food Preservation Method For Consumers, Retailers, And Food Industries. However, Supercooling Of Fish, Of Which Perishability Remains The Biggest Challenge For Storage, Is New | $175,000 |
Federal grant · SBIR/STTR
Peer position
| # | Company | Contracts | Disclosed equity |
|---|---|---|---|
| 1110 | EMMUNE INC | — | — |
| 1111 | EPPIN PHARMA, INC. | — | — |
| 1112 | DiaMedica Therapeutics Inc. | — | $110M |
| 1113 | JUN INNOVATIONS INC | — | — |
| 1114 | COMPANION SCIENCES, INC. | — | — |
| 1115 | Mu Therapeutics Inc. | — | — |
| 1116 | OPERATIONAL TECHNOLOGIES CORPORATION | — | — |
Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.
Regulatory activity · Biotech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.